Br. J. Dermatol.
· May 1975
Clinical Trial
Controlled Clinical Trial
A new formulation of hydrocortisone with vasoconstrictor activity has been shown to be effective clinically and was more effective in a 0.1% concentration than 1.0% Hydrocortisone Cream BPC. Its use should obviate the adverse effects of fluorinated steroids.
read on…
or not…
no abstract available
read on…
or not…